IfPA’s Patient Access Policy Blog

“Death Panel” Trigger Could Limit Medicare Access

Once dubbed a “death panel”, the Independent Payment Advisory Board is back in the news. The board was devised under the Affordable Care Act as

Read More

HHS Reports Tout Value of Hepatitis C Treatment, Screening

Two new publications point to the value of treating hepatitis C – early, aggressively and alongside heightened screening efforts. Expert Consultation Report The Department of

Read More

New Opioid Guidelines, Same Coverage Quandry

New pain treatment guidelines underscore a now familiar disconnect: the gap between what patients need and what their health plans will pay for. The American

Read More

Rare Disease Day Spotlights Need for Research

Rare Disease Day brings international attention to the plight of patients who struggle with ALS, Gaucher disease, cystic fibrosis and other less common conditions.  This

Read More

New Cystic Fibrosis Group Weighs in on Obamacare Revamp

As Congress continues to debate the future of the Affordable Care Act, a new advocacy group has a message for key legislators: protect cystic fibrosis

Read More

Does ICER Model Work for Rheumatoid Arthritis Treatments?

The Institute for Clinical and Economic Review’s newest cost-effectiveness report underscores just how far economic modeling sometimes diverges from patients’ reality, explained the Institute for

Read More

Fewer Treatment Choices and Higher Costs Plague Diabetes Patients

Access to medication has become an all-too-common challenge for patients with one of the country’s most common diseases: diabetes. Several health plans announced in late

Read More

Why Impact & Cost of Chronic Migraine Comorbidities Justify “Whole-Person” Care

Chronic migraine is seldom a lone condition, explains a new white paper from the Headache & Migraine Policy Forum.  And when chronic migraine patients suffer

Read More

Trials Data Strengthens Patients’ Demands for Breakthrough Cholesterol Meds

New data on PCSK9 inhibitors is in – and it may bolster patients’ demands for the breakthrough cholesterol drugs in the face of health plan

Read More

Rising Cancer Survivorship Brings New Policy Challenges

More patients are living longer with cancer – and that’s good news.  But some face policies, health care providers and workplaces that are unprepared to

Read More
Back to Top